470PClinical development program for efgartigimod in juvenile generalized myasthenia gravis

Neuromuscular Disorders, vol. 53, pp. 106107

Authors 10

1. Sithara Ramdas

   John Radcliffe Hospital · University of Oxford

   Affiliation as printed

   Dept Paediatric Neurology, John Radcliffe Hospital, Oxford, UK

   MDUK Oxford Neuromuscular Centre, Dept Paediatrics, University of Oxford, Oxford, UK

2. Nancy L. Kuntz

   Northwestern University · Lurie Children's Hospital

   Affiliation as printed

   Div Neurology, Dept Pediatrics, Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, USA

3. Abigail Schwaede

   Northwestern University · Lurie Children's Hospital

   Affiliation as printed

   Div Neurology, Dept Pediatrics, Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, USA

4. Anna Bogatyreva

   Argenx (Belgium)

   Affiliation as printed

   argenx, Ghent, Belgium

5. Jyoti Dalvi

   Argenx (Belgium)

   Affiliation as printed

   argenx, Ghent, Belgium

6. Juliette Giacobbe

   Argenx (Belgium)

   Affiliation as printed

   argenx, Ghent, Belgium

7. Lei Liu

   Argenx (Belgium)

   Affiliation as printed

   argenx, Ghent, Belgium

8. Tonke Van Bragt
   Affiliation as printed

   Curare Consulting BV, Liempde, Netherlands

9. Erik Harmen Niks Aachen Department Neurology Leiden Univ Med Center

   Leiden University Medical Center

   Affiliation as printed

   Dept Neurology, Leiden Univ Med Center, Leiden, Netherlands

10. Anna Kostera‐Pruszczyk

    Medical University of Warsaw

    Affiliation as printed

    Medical University of Warsaw, Warsaw, Poland